Meerwein-Ponndorf-Verley-type reduction of dicarbonyl compounds to hydroxy carbonyl compounds and .alpha.,.beta.-unsaturated carbonyl compounds to allylic alcohols catalyzed by zirconocene and hafnocene complexes
3-(5-HYDROXY-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF
申请人:Novartis AG
公开号:US20200017461A1
公开(公告)日:2020-01-16
The present disclosure provides a compound of Formula (I′):
or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, wherein R
x
, X
1
, X
2
, and R
1
are as defined herein, and methods of making and using same.
Catalytic epoxidation of alkenes by co-ordinatively unsaturated phosphino complexes of ruthenium(II) and osmium(II)
作者:Mario Bressan、Antonino Morvillo
DOI:10.1039/c39880000650
日期:——
Ruthenium(II) and osmium(II) complexes [MCl(LL)2]Y, where LL is 1,3-bis(diphenylphosphino)propane or 1-diphenylphosphino-2-(2′-pyridyl)ethane, promote the oxidation of a number of alkenes by PhIO, hypochlorites, and H2O2.
钌(II)和(II)配合物[MCl(LL)2 ] Y,其中LL为1,3-双(二苯基膦基)丙烷或1-二苯基膦基-2-(2'-吡啶基)乙烷,可促进氧化PhIO,次氯酸盐和H 2 O 2形成许多烯烃。
[EN] COMPOUNDS AND THEIR METHODS OF USE<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES ET LEURS PROCÉDÉS D'UTILISATION
申请人:AGIOS PHARMACEUTICALS INC
公开号:WO2014079150A1
公开(公告)日:2014-05-30
Provided are compounds of formula (I), which can inhibit glutaminase. Pharmaceutical compositions comprising these compounds and uses as glutaminase inhibitors for treating cancers thereof are also provided.
from the results observed with strained and sterically hindered syn 1,2-diols, which undergo oxidative cleavage via a 12-I-5 spirobicyclic periodinane. The use of TFA, a protonating solvent, promotes the formation of the 12-I-5 intermediate for 1,2-diols of all types (sec,sec, sec,tert and tert,tert), leading to efficient oxidative fragmentation.
[EN] HETEROCYCLIC COMPOUNDS FOR INHIBITING GLUTAMINASE AND THEIR METHODS OF USE<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES POUR INHIBER LA GLUTAMINASE ET PROCÉDÉS D'UTILISATION DE CEUX-CI
申请人:AGIOS PHARMACEUTICALS INC
公开号:WO2014079011A1
公开(公告)日:2014-05-30
Compounds and compositions comprising compounds that inhibit glutaminase are described herein. Also described herein are methods of using the compounds that inhibit glutaminase in the treatment of cancer.